KYAN Therapeutics, Inc.

KYAN Therapeutics is a clinical-stage artificial intelligence company leveraging its proprietary technology platforms to transform the way patients are treated and therapies are developed. KYAN is able to revolutionize the drug development and dosage optimization processes and has multiple pipeline combination therapies in development for oncology and infectious diseases. KYAN de-risks and dramatically accelerates the drug development process, identifying novel combination therapies with unprecedented efficacy and safety. KYAN's clinically-validated platforms are uniquely disease-mechanism and indication agnostic.